A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Gershenson, DM; Miller, A; Brady, W; Paul, J; Carty, K; Rodgers, W; Millan, D; Coleman, RL; Moore, KN; Banerjee, S; Connolly, K; Secord, AA; O'Malley, DM; Dorigo, O; Gaillard, S; Gabra, H; Hanjani, P; Huang, H; Wenzel, L; Gourley, C

Published Date

  • October 1, 2019

Published In

Volume / Issue

  • 30 /

Published By


  • 2

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 44th Congress of the European-Society-for-Medical-Oncology (ESMO)

Conference Location

  • Barcelona, SPAIN

Conference Start Date

  • September 27, 2019

Conference End Date

  • October 1, 2019